Endofotonics

Endofotonics is rated 3 out of 5 in the category medical devices. Read and write reviews about Endofotonics. Endofotonics is a medtech startup from Singapore. We are developing the world's first diagnostic biopsy device to assist clinicians on selecting the best informed biopsy during endoscopy. This medical device, called SPECTRA IMDx system, is utilizing state-of-art fiber-optic Raman optic technology and machine learning algorithm in detecting specific precancerous and cancerous tissue in-vivo. Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field. Endofotonics is also an investee of Zicom MedTacc, medtech accelerator, which we receive strong assistance in business capabilities and relationship with key industry partners; legal and regulatory affairs. Endofotonics is currently at the product development phase of the IMDx system. The system is a Raman spectroscopy with an extension of a confocal fiberoptic probe; with machine learning capabilities. The whole console system will be used by clinicians in surgical theater.